AddThis Feed Button "Frequently Copied, Never Duplicated"

Monday, May 26, 2008

Fluoride based drug with Black Box warning urged for cancer patients

The following is the Black Box warning for Celexa.
Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of Celexa or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Celexa is not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.)

In addition, Celexa is another fluoride based SSRI.

Fluoride suppresses thyroid function which can then lead to suppressed immunity.

No one is considering that the toxic load from chemo and radiation treatments as well as associated nutritional deficiencies may be the cause of the "depression".

Cancer therapies do need a newer approach.

No comments: